一般用医薬品の世界市場レポート 2025年

一般用医薬品市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.0%で、2,117億米ドルに成長します。予測期間の成長は、セルフメディケーションの増加、小売流通チャネルの拡大、慢性疾患負担、製品イノベーション、世界の健康動向に起因すると考えられます。予測期間における主な動向としては、自然療法やハーブ療法に対する需要の高まり、eコマースプラットフォームの拡大、個別化医療と標的療法、予防医療の重視、デジタルヘルス技術の統合などが挙げられます。

生活習慣に関連した健康問題の増加が予想されることから、将来的には一般用医薬品（OTC）市場の拡大が見込まれます。これらの健康問題は、食事、運動、物質使用、ストレス管理などの分野における個人の習慣や選択に影響され、現代のライフスタイルによりますます蔓延しています。座りがちな生活習慣、食生活の乱れ、喫煙、過度のアルコール摂取、ストレスレベルの高まりなどが、この動向に拍車をかけています。OTC医薬品は、現代生活に関連する一般的な症状を管理するための便利で利用しやすい手段を提供し、ライフスタイルに関連する健康問題に対処する上で重要な役割を果たしています。例えば、2022年3月現在、世界保健機関（WHO）の報告によると、世界全体で約10億人が肥満であり、今後も増加すると予測されています。2025年までに、1億6,700万人の大人と子どもが、体重過多による健康被害を受けると推定されています。さらに、2021年の国際糖尿病連合によると、糖尿病患者数は2030年までに6億4,300万人、2045年までに7億8,300万人に増加すると予想されています。これらの統計は、生活習慣に関連する健康上の懸念に対処することの重要性が高まっていることを強調するものであり、それによってOTC医薬品の需要に拍車をかけています。

OTC医薬品市場の主なプレーヤーは、店頭用スプレーのような新規製品の開発に重点を置き、競争優位性を獲得するために技術革新を活用しています。これらのスプレーは、身体の標的部位に治療薬を直接投与する、使いやすく効果的な方法を提供します。例えば、2023年8月、米国のバイオテクノロジー企業であるEmergent BioSolutions Inc.は、市販薬のNARCAN Naloxone HCl Nasal Spray 4mgを発表しました。この製品は、フェンタニルのような強力な合成オピオイドを含むオピオイドの作用を迅速に逆転させる手段を提供するもので、医療訓練を受けていない人でも迅速な緊急対応が可能です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界一般用医薬品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の一般用医薬品市場：成長率分析
• 世界の一般用医薬品市場の実績：規模と成長, 2019-2024
• 世界の一般用医薬品市場の予測：規模と成長, 2024-2029, 2034F
• 世界一般用医薬品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の一般用医薬品市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 咳、風邪、インフルエンザ対策
• 鎮痛剤
• 皮膚科製品
• 胃腸薬
• ビタミン、ミネラル、サプリメント（VMS）
• 減量またはダイエット製品
• 眼科用製品
• 睡眠補助剤
• その他の製品タイプ
• 世界の一般用医薬品市場処方タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• 液体
• 軟膏
• スプレー
• 世界の一般用医薬品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• その他のチャンネル
• 世界の一般用医薬品市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 専門クリニック
• ホームケア
• 病院
• その他のエンドユーザー
• 世界の一般用医薬品市場咳止め、風邪薬、インフルエンザ薬の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 咳止めシロップ
• 鼻づまり解消薬
• 風邪とインフルエンザの錠剤
• ロゼンジと喉スプレー
• 鼻スプレー
• 世界の一般用医薬品市場鎮痛剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 鎮痛錠（イブプロフェン、アセトアミノフェン）
• 局所鎮痛剤（クリーム、ジェル）
• 複合鎮痛剤（アスピリン＋カフェイン）
• 世界の一般用医薬品市場皮膚科製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニキビ治療
• スキンモイスチャライザーとクリーム
• アンチエイジング製品
• 日焼け止め
• 局所抗真菌薬および消毒薬
• 世界の一般用医薬品市場消化器系製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 制酸剤
• 下剤
• 消化酵素
• プロバイオティクス
• 下痢止め薬
• 世界の一般用医薬品市場ビタミン、ミネラル、サプリメント（VMS）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ビタミンサプリメント（ビタミンC、ビタミンD）
• ミネラルサプリメント（鉄、マグネシウム）
• ハーブサプリメント
• プロバイオティクスとプレバイオティクス
• オメガ3と魚油
• 世界の一般用医薬品市場減量またはダイエット製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 減量薬
• 食事代替品
• 食欲抑制剤
• 脂肪燃焼剤
• 世界の一般用医薬品市場眼科用製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 点眼薬（潤滑剤、抗ヒスタミン剤）
• 人工涙液
• コンタクトレンズソリューション
• 眼軟膏
• 世界の一般用医薬品市場睡眠補助剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• メラトニンサプリメント
• ハーブ睡眠補助剤（バレリアン根、カモミール）
• 市販の睡眠薬
• 世界の一般用医薬品市場、その他の製品タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 禁煙補助製品（ニコチンパッチ、ガム）
• 抗アレルギー薬（抗ヒスタミン薬）
• 救急用品（包帯、消毒クリーム）
• 女性用衛生用品（膣の健康サプリメント）

第7章 地域別・国別分析

• 世界の一般用医薬品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の一般用医薬品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 一般用医薬品市場：競合情勢
• 一般用医薬品市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• AbbVie Inc.
• Bayer AG
• Sanofi S.A.
• Bristol Myers Squibb Company
• AstraZeneca PLC
• Novartis AG
• GlaxoSmithKline PLC
• Takeda Pharmaceutical Company Ltd.
• Novo Nordisk A/S
• Reckitt Benckiser Group PLC
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• DAIICHI SANKYO COMPANY LIMITED
• Sun Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 一般用医薬品市場2029：新たな機会を提供する国
• 一般用医薬品市場2029：新たな機会を提供するセグメント
• 一般用医薬品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Over-the-counter (OTC) drugs are medications that can be obtained without a prescription from a healthcare professional. These drugs are deemed safe and effective for use by the general public when adhering to the instructions provided on the label. Typically, OTC drugs target minor health conditions and symptoms such as headaches, colds, allergies, pain, and digestive issues.

The primary product categories of OTC drugs encompass cough, cold, and flu products, analgesics, dermatology products, gastrointestinal products, vitamins, minerals, and supplements (VMS), weight loss or dietary products, ophthalmic products, sleeping aids, and others. For instance, cough, cold, and flu products are formulated to alleviate symptoms associated with respiratory infections, including coughing, congestion, and fever, and are available in various formulations such as tablets, liquids, ointments, and sprays. OTC drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and others, and are utilized by a diverse range of end-users, primarily specialty clinics, homecare, hospitals, among others.

The over the counter (OTC) drugs market research report is one of a series of new reports from The Business Research Company that provides over the counter (OTC) drugs market statistics, including over the counter (OTC) drugs industry global market size, regional shares, competitors with a over the counter (OTC) drugs market share, detailed over the counter (OTC) drugs market segments, market trends and opportunities, and any further data you may need to thrive in the over the counter (OTC) drugs industry. This over the counter (OTC) drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The over the counter (OTC) drugs market size has grown strongly in recent years. It will grow from $158.26 billion in 2024 to $167.92 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to regulatory changes, consumer awareness, healthcare accessibility, demographic trends, and economic factors.

The over the counter (OTC) drugs market size is expected to see strong growth in the next few years. It will grow to $211.7 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to increasing self-medication practices, expanding retail distribution channels, chronic disease burden, product innovation, and global health trends. Major trends in the forecast period include rising demand for natural and herbal remedies, expansion of e-commerce platforms, personalized medicine and targeted therapies, emphasis on preventive healthcare, and integration of digital health technologies.

The anticipated rise in lifestyle-related health issues is set to drive the expansion of the over-the-counter (OTC) drugs market in the future. These health issues, influenced by individual habits and choices in areas such as diet, exercise, substance use, and stress management, have become increasingly prevalent due to modern lifestyles. Sedentary habits, poor dietary choices, smoking, excessive alcohol consumption, and heightened stress levels contribute to this trend. OTC drugs offer a convenient and accessible means of managing common conditions associated with contemporary living, playing a significant role in addressing lifestyle-related health issues. For example, as of March 2022, the World Health Organization reported that globally, around 1 billion individuals were obese, with projections indicating a continued increase. By 2025, it is estimated that 167 million adults and children will suffer health consequences due to excess weight. Additionally, according to the International Diabetes Federation in 2021, the number of individuals living with diabetes is expected to rise to 643 million by 2030 and 783 million by 2045. These statistics underscore the growing importance of addressing lifestyle-related health concerns, thereby fueling the demand for OTC drugs.

Key players in the OTC drug market are leveraging innovation to gain a competitive edge, with a focus on developing novel products such as over-the-counter sprays. These sprays offer a user-friendly and effective way to administer therapeutic agents directly to targeted areas of the body. For instance, in August 2023, Emergent BioSolutions Inc., a US-based biotech company, introduced its over-the-counter NARCAN Naloxone HCl Nasal Spray 4 mg. This product provides a rapid means of reversing opioid effects, including those of potent synthetic opioids such as fentanyl, facilitating quick emergency response, even among individuals without medical training.

In September 2023, Cipla South Africa, a subsidiary of India-based Cipla Limited, acquired Actor Pharma (Pty) Ltd. for $49 million. This acquisition expanded Cipla's portfolio of consumer brands and enhanced its presence in the South African OTC pharmaceutical market. Actor Pharma specializes in generic and OTC medicines, aligning with Cipla's goal of catering to diverse healthcare needs and strengthening its position in key markets.

Major companies operating in the over the counter (OTC) drugs market are Pfizer Inc., Johnson & Johnson Private Limited, The Procter & Gamble Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Novo Nordisk A/S, Reckitt Benckiser Group PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Perrigo Company plc, Cipla Inc., Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd.

North America was the largest region in the over the counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over the counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the over the counter (OTC) drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over-the-counter (OTC) drugs market consists of sales of pain relievers, allergy medications, first aid supplies, anti-diarrheal medications, and nasal sprays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter (OTC) Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter (otc) drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for over the counter (otc) drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The over the counter (otc) drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Cough, Cold And Flu Products; Analgesics; Dermatology Products; Gastrointestinal Products; Vitamins, Mineral And Supplements (VMS); Weight Loss Or Dietary Products; Ophthalmic Products; Sleeping Aids; Other Product Types
• 2) By Formulation Type: Tablets; Liquids; Ointments; Sprays
• 3) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Channels
• 4) By End-Users: Specialty Clinics; Homecare; Hospitals; Other End Users
• Subsegments:
• 1) By Cough, Cold, And Flu Products: Cough Syrups; Decongestants; Cold And Flu Tablets; Lozenges And Throat Sprays; Nasal Sprays
• 2) By Analgesics: Pain Relief Tablets (Buprofen, Acetaminophen); Topical Pain Relief (Creams, Gels); Combination Pain Relievers ( Aspirin + Caffeine)
• 3) By Dermatology Products: Acne Treatments; Skin Moisturizers And Creams; Anti-Aging Products; Sunscreens; Topical Antifungals And Antiseptics
• 4) By Gastrointestinal Products: Antacids; Laxatives; Digestive Enzymes; Probiotics; Anti-diarrheal Medications
• 5) By Vitamins, Mineral, And Supplements (Vms): Vitamin Supplements ( Vitamin C, Vitamin D); Mineral Supplements ( Iron, Magnesium); Herbal Supplements; Probiotics And Prebiotics; Omega-3 And Fish Oil
• 6) By Weight Loss Or Dietary Products: Weight Loss Pills; Meal Replacements; Appetite Suppressants; Fat Burners
• 7) By Ophthalmic Products: Eye Drops (Lubricating, Antihistamine); Artificial Tears; Contact Lens Solutions; Eye Ointments
• 8) By Sleeping Aids: Melatonin Supplements; Herbal Sleep Aids ( Valerian Root, Chamomile); Over-The-Counter Sleep Tablets
• 9) By Other Product Types: Smoking Cessation Products (Nicotine Patches, Gum); Anti-Allergy Medications (Antihistamines); First Aid Supplies (Bandages, Antiseptic Creams); Feminine Hygiene Products (Vaginal Health Supplements)
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; The Procter & Gamble Company; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Over The Counter (OTC) Drugs Market Characteristics

3. Over The Counter (OTC) Drugs Market Trends And Strategies

4. Over The Counter (OTC) Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Over The Counter (OTC) Drugs Growth Analysis And Strategic Analysis Framework

• 5.1. Global Over The Counter (OTC) Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Over The Counter (OTC) Drugs Market Growth Rate Analysis
• 5.4. Global Over The Counter (OTC) Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Over The Counter (OTC) Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Over The Counter (OTC) Drugs Total Addressable Market (TAM)

6. Over The Counter (OTC) Drugs Market Segmentation

• 6.1. Global Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cough, Cold And Flu Products
• Analgesics
• Dermatology Products
• Gastrointestinal Products
• Vitamins, Mineral And Supplements (VMS)
• Weight Loss Or Dietary Products
• Ophthalmic Products
• Sleeping Aids
• Other Product Types
• 6.2. Global Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Liquids
• Ointments
• Sprays
• 6.3. Global Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Other Channels
• 6.4. Global Over The Counter (OTC) Drugs Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Specialty Clinics
• Homecare
• Hospitals
• Other End Users
• 6.5. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Cough, Cold, And Flu Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cough Syrups
• Decongestants
• Cold And Flu Tablets
• Lozenges And Throat Sprays
• Nasal Sprays
• 6.6. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Analgesics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pain Relief Tablets (Ibuprofen, Acetaminophen)
• Topical Pain Relief (Creams, Gels)
• Combination Pain Relievers (Aspirin + Caffeine)
• 6.7. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Dermatology Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acne Treatments
• Skin Moisturizers And Creams
• Anti-Aging Products
• Sunscreens
• Topical Antifungals And Antiseptics
• 6.8. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Gastrointestinal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antacids
• Laxatives
• Digestive Enzymes
• Probiotics
• Anti-diarrheal Medications
• 6.9. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Vitamins, Mineral, And Supplements (VMS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vitamin Supplements (Vitamin C, Vitamin D)
• Mineral Supplements (Iron, Magnesium)
• Herbal Supplements
• Probiotics And Prebiotics
• Omega-3 And Fish Oil
• 6.10. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Weight Loss Or Dietary Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Weight Loss Pills
• Meal Replacements
• Appetite Suppressants
• Fat Burners
• 6.11. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Ophthalmic Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Drops (Lubricating, Antihistamine)
• Artificial Tears
• Contact Lens Solutions
• Eye Ointments
• 6.12. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Sleeping Aids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Melatonin Supplements
• Herbal Sleep Aids (Valerian Root, Chamomile)
• Over-The-Counter Sleep Tablets
• 6.13. Global Over The Counter (OTC) Drugs Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Smoking Cessation Products (Nicotine Patches, Gum)
• Anti-Allergy Medications (Antihistamines)
• First Aid Supplies (Bandages, Antiseptic Creams)
• Feminine Hygiene Products (Vaginal Health Supplements)

7. Over The Counter (OTC) Drugs Market Regional And Country Analysis

• 7.1. Global Over The Counter (OTC) Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Over The Counter (OTC) Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Over The Counter (OTC) Drugs Market

• 8.1. Asia-Pacific Over The Counter (OTC) Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Over The Counter (OTC) Drugs Market

• 9.1. China Over The Counter (OTC) Drugs Market Overview
• 9.2. China Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Over The Counter (OTC) Drugs Market

• 10.1. India Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Over The Counter (OTC) Drugs Market

• 11.1. Japan Over The Counter (OTC) Drugs Market Overview
• 11.2. Japan Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Over The Counter (OTC) Drugs Market

• 12.1. Australia Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Over The Counter (OTC) Drugs Market

• 13.1. Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Over The Counter (OTC) Drugs Market

• 14.1. South Korea Over The Counter (OTC) Drugs Market Overview
• 14.2. South Korea Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Over The Counter (OTC) Drugs Market

• 15.1. Western Europe Over The Counter (OTC) Drugs Market Overview
• 15.2. Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Over The Counter (OTC) Drugs Market

• 16.1. UK Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Over The Counter (OTC) Drugs Market

• 17.1. Germany Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Over The Counter (OTC) Drugs Market

• 18.1. France Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Over The Counter (OTC) Drugs Market

• 19.1. Italy Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Over The Counter (OTC) Drugs Market

• 20.1. Spain Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Over The Counter (OTC) Drugs Market

• 21.1. Eastern Europe Over The Counter (OTC) Drugs Market Overview
• 21.2. Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Over The Counter (OTC) Drugs Market

• 22.1. Russia Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Over The Counter (OTC) Drugs Market

• 23.1. North America Over The Counter (OTC) Drugs Market Overview
• 23.2. North America Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Over The Counter (OTC) Drugs Market

• 24.1. USA Over The Counter (OTC) Drugs Market Overview
• 24.2. USA Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Over The Counter (OTC) Drugs Market

• 25.1. Canada Over The Counter (OTC) Drugs Market Overview
• 25.2. Canada Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Over The Counter (OTC) Drugs Market

• 26.1. South America Over The Counter (OTC) Drugs Market Overview
• 26.2. South America Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Over The Counter (OTC) Drugs Market

• 27.1. Brazil Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Over The Counter (OTC) Drugs Market

• 28.1. Middle East Over The Counter (OTC) Drugs Market Overview
• 28.2. Middle East Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Over The Counter (OTC) Drugs Market

• 29.1. Africa Over The Counter (OTC) Drugs Market Overview
• 29.2. Africa Over The Counter (OTC) Drugs Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Over The Counter (OTC) Drugs Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Over The Counter (OTC) Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Over The Counter (OTC) Drugs Market Competitive Landscape And Company Profiles

• 30.1. Over The Counter (OTC) Drugs Market Competitive Landscape
• 30.2. Over The Counter (OTC) Drugs Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. The Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Over The Counter (OTC) Drugs Market Other Major And Innovative Companies

• 31.1. AbbVie Inc.
• 31.2. Bayer AG
• 31.3. Sanofi S.A.
• 31.4. Bristol Myers Squibb Company
• 31.5. AstraZeneca PLC
• 31.6. Novartis AG
• 31.7. GlaxoSmithKline PLC
• 31.8. Takeda Pharmaceutical Company Ltd.
• 31.9. Novo Nordisk A/S
• 31.10. Reckitt Benckiser Group PLC
• 31.11. Viatris Inc.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. DAIICHI SANKYO COMPANY LIMITED
• 31.14. Sun Pharmaceutical Industries Ltd.
• 31.15. Boehringer Ingelheim International GmbH

32. Global Over The Counter (OTC) Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over The Counter (OTC) Drugs Market

34. Recent Developments In The Over The Counter (OTC) Drugs Market

35. Over The Counter (OTC) Drugs Market High Potential Countries, Segments and Strategies

• 35.1 Over The Counter (OTC) Drugs Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Over The Counter (OTC) Drugs Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Over The Counter (OTC) Drugs Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer